SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

Area of Science:

• Oncology
• Endocrinology

Background:

• Thyroid cancer (TC) accounts for 3% of worldwide cancer diagnoses.
• Evolving treatment strategies involve risk stratification, molecular analysis, and advanced imaging.
• Targeted therapies are increasingly modifying the disease's natural progression.

Purpose of the Study:

• To present a comprehensive and practical overview of current thyroid cancer management.
• To detail the latest updates in diagnosis, treatment, and long-term follow-up for TC.
• To address the growing complexity of treatment options in TC.

Main Methods:

• Review of current literature and clinical guidelines on thyroid cancer.
• Analysis of risk assessment, molecular profiling, and imaging techniques.
• Synthesis of data for a practical management approach.

Main Results:

• Optimized treatment decisions are now based on integrated risk assessment, molecular data, and imaging.
• Targeted agents have significantly impacted the natural history of thyroid cancer.
• A multi-faceted approach is crucial from diagnosis through long-term surveillance.

Conclusions:

• Effective thyroid cancer management necessitates careful assessment at all disease stages.
• This guideline offers a practical framework for current and updated TC care.
• The evolving landscape of TC treatment requires continuous adaptation of clinical strategies.